<DOC>
	<DOC>NCT01802359</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of mirodenafil in participants with erectile dysfunction.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction</brief_title>
	<detailed_description>This is a non randomized (the study medication is not assigned by chance), open-label (all participants and study staff know the identity of the treatment), multi-center, prospective (looking forward using observations collected following participant enrollment), and non-comparative study in which participants with erectile dysfunction will be observed to evaluate the safety and effectiveness of mirodenafil for 12 weeks. Safety evaluations will include assessment of adverse events, and record of concomitant medications. The study will be conducted in Korea.</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Mirodenafil</mesh_term>
	<criteria>Participants diagnosed with erectile dysfunction Participants prescribed mirodenafil on demand Participants who have administered mirodenafil for other than an approved indication</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Mirodenafil</keyword>
	<keyword>Bravonto</keyword>
</DOC>